2017 CINP指南:成人双相障碍的治疗

2016-12-10 国际神经精神药理学学会 Int J Neuropsychopharmacol. 2016 Dec 10

2016年12月,国际神经精神药理学会(CINP)发布了成人双相障碍治疗指南(CINP-BD-2017)。该指南在整合最新循证学证据的同时高度兼顾了临床实用性,强调单药治疗优于联合治疗,并为双相障碍每一时相制订了严格的五步治疗流程。

中文标题:

2017 CINP指南:成人双相障碍的治疗

英文标题:

The International College of Neuro-Psychopharmacology CINP treatment guidelines for Bipolar disorder in adults CINP-BD-2017, part 3: The clinical guidelines.

发布日期:

2016-12-10

简要介绍:

2016年12月,国际神经精神药理学会(CINP)发布了成人双相障碍治疗指南(CINP-BD-2017)。该指南在整合最新循证学证据的同时高度兼顾了临床实用性,强调单药治疗优于联合治疗,并为双相障碍每一时相制订了严格的五步治疗流程。


拓展指南:双相障碍相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=2017 CINP指南:成人双相障碍的治疗)] GetToolGuiderByIdResponse(projectId=1, id=cd7111c00136202e, title=2017 CINP指南:成人双相障碍的治疗, enTitle=The International College of Neuro-Psychopharmacology CINP treatment guidelines for Bipolar disorder in adults CINP-BD-2017, part 3: The clinical guidelines., guiderFrom=Int J Neuropsychopharmacol. 2016 Dec 10, authorId=null, author=, summary=2016年12月,国际神经精神药理学会(CINP)发布了成人双相障碍治疗指南(CINP-BD-2017)。该指南在整合最新循证学证据的同时高度兼顾了临床实用性,强调单药治疗优于联合治疗,并为双相障碍每一时相制订了严格的五步治疗流程。, cover=, journalId=null, articlesId=null, associationId=1361, associationName=国际神经精神药理学学会, associationIntro=, copyright=0, guiderPublishedTime=Sat Dec 10 00:00:00 CST 2016, originalUrl=, linkOutUrl=, content=2016年12月,国际神经精神药理学会(CINP)发布了成人双相障碍治疗指南(CINP-BD-2017)。该指南在整合最新循证学证据的同时高度兼顾了临床实用性,强调单药治疗优于联合治疗,并为双相障碍每一时相制订了严格的五步治疗流程。 <div><br> </div> 拓展指南:<strong>与<font color="red">双相障碍</font>相关指南:</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=a66f71c001112660" title="2014 NICE临床指南:在初级和二级医疗中成人,儿童以及青年人双相障碍的评估和管理(CG185)" target="_blank">2014 NICE临床指南:在初级和二级医疗中成人,儿童以及青年人双相障碍的评估和管理(CG185)</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=aedb41c001013801" title="2013 ISBD 双相障碍中抑郁药应用工作报告" target="_blank">2013 ISBD 双相障碍中抑郁药应用工作报告</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=b52411c00099e762" title="2013 双相障碍抑郁发作药物治疗专家建议" target="_blank">2013 双相障碍抑郁发作药物治疗专家建议</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=6c6961c000955a1a" title="2013年加拿大焦虑与心境障碍治疗网络双相障碍治疗指南(更新版)" target="_blank">2013年加拿大焦虑与心境障碍治疗网络双相障碍治疗指南(更新版)</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=9af871c00090e027" title="2012 丙戊酸镁缓释片治疗双相障碍临床应用的专家共识" target="_blank">2012 丙戊酸镁缓释片治疗双相障碍临床应用的专家共识</a></li> 更多信息请点击:<a href="http://www.medsci.cn/guideline/list.do?q=%E5%8F%8C%E7%9B%B8%E9%9A%9C%E7%A2%8D" target="_blank">有关双相障碍更多指南</a></ul>, tagList=[TagDto(tagId=8327, tagName=双相障碍)], categoryList=[CategoryDto(categoryId=13, categoryName=精神心理科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=0, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=4294, appHits=248, showAppHits=0, pcHits=2820, showPcHits=1850, likes=134, shares=18, comments=2, approvalStatus=1, publishedTime=Wed Feb 15 14:15:55 CST 2017, publishedTimeString=2016-12-10, pcVisible=1, appVisible=1, editorId=5295978, editor=weiqi, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=weiqi, createdTime=Wed Feb 15 14:15:55 CST 2017, updatedBy=null, updatedName=null, updatedTime=Tue Jan 02 12:10:16 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2017 CINP指南:成人双相障碍的治疗)])
2017 CINP指南:成人双相障碍的治疗
下载请点击:
评论区 (2)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=949529, encodeId=e23094952996, content=2017年的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201103/ac33bf6bc95b41be9e96f354db611eb9/d31d7d39648c4b9ab92afe88f5ec07ea.jpg, createdBy=ea225431246, createdName=山灰柴, createdTime=Fri Mar 19 17:11:21 CST 2021, time=2021-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=176340, encodeId=c69f1e634073, content=学习啦谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/12/31/60fc0213ae09a3dbbba19993663ef4db.jpg, createdBy=33c31971480, createdName=1e160a78m83(暂无匿称), createdTime=Wed Feb 15 22:21:06 CST 2017, time=2017-02-15, status=1, ipAttribution=)]
    2021-03-19 山灰柴

    2017年的

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=949529, encodeId=e23094952996, content=2017年的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201103/ac33bf6bc95b41be9e96f354db611eb9/d31d7d39648c4b9ab92afe88f5ec07ea.jpg, createdBy=ea225431246, createdName=山灰柴, createdTime=Fri Mar 19 17:11:21 CST 2021, time=2021-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=176340, encodeId=c69f1e634073, content=学习啦谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/12/31/60fc0213ae09a3dbbba19993663ef4db.jpg, createdBy=33c31971480, createdName=1e160a78m83(暂无匿称), createdTime=Wed Feb 15 22:21:06 CST 2017, time=2017-02-15, status=1, ipAttribution=)]
    2017-02-15 1e160a78m83(暂无匿称)

    学习啦谢谢分享

    0